<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="5" ids="47916">Flavonoids</z:chebi> have been intensively studied on their pharmacological activities such as anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, anti-oxidant and anti-<z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, little is known about their neuroprotective effects </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies suggest that <z:mp ids='MP_0001845'>inflammation</z:mp> mediated by microglia may play a role in <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we evaluated the anti-inflammatory effect of various <z:chebi fb="5" ids="47916">flavonoid</z:chebi> compounds by using BV-2, a murine microglia cell line </plain></SENT>
<SENT sid="4" pm="."><plain>Of the compounds that were evaluated, <z:chebi fb="0" ids="18388">apigenin</z:chebi> inhibited the production of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E(2) by suppressing the expression of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase and cyclooxygenase-2 protein, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, <z:chebi fb="0" ids="18388">apigenin</z:chebi> suppressed p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK) phosphorylation without affecting the activity of extracellular signal-regulated kinase (ERK) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="18388">Apigenin</z:chebi> was also found to protect neuronal cells from injury in middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
</text></document>